Baber, Usman <br/><br/>
Associations Between Chronic Kidney Disease and Outcomes With Use of Prasugrel Versus Clopidogrel in Patients With Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention: A Report From the PROMETHEUS Study.  [electronic resource] 

 -  JACC. Cardiovascular interventions  10 2017 
 - 2017-2025 p.  digital 
<br/><br/> Publication Type: Comparative Study; Journal Article; Multicenter Study; Observational Study; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1876-7605 
<br/><br/><label>Standard No.: </label>10.1016/j.jcin.2017.02.047  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Acute Coronary Syndrome--complications<br/>Aged<br/>Aged, 80 and over<br/>Chi-Square Distribution<br/>Clopidogrel<br/>Coronary Thrombosis--etiology<br/>Databases, Factual<br/>Hemorrhage--chemically induced<br/>Humans<br/>Kaplan-Meier Estimate<br/>Kidney--physiopathology<br/>Male<br/>Middle Aged<br/>Multivariate Analysis<br/>Myocardial Infarction--etiology<br/>Percutaneous Coronary Intervention--adverse effects<br/>Platelet Aggregation Inhibitors--administration & dosage<br/>Prasugrel Hydrochloride--administration & dosage<br/>Propensity Score<br/>Proportional Hazards Models<br/>Renal Insufficiency, Chronic--complications<br/>Risk Factors<br/>Stroke--etiology<br/>Ticlopidine--administration & dosage<br/>Time Factors<br/>Treatment Outcome<br/>United States